Skip to content

TERNTERNS PHARMACEUTICALS INC

CUSIP 880881107 · common stock

No tracked investor reported shares of TERNS PHARMACEUTICALS INC (TERN) for Q2 2026. 4 investors sold out this quarter, including Adar1 Capital Management.

Holders · Q2 2026
0
New holders
0
Value held
$0
Quarter-end price (est.)
—

Investors holding TERN · Q2 2026

No tracked investor reported shares this quarter.

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Adar1 Capital Management2.84%914,699$48.2MEXIT
George Soros0.19%321,905$17MEXIT
Ron Baron0.01%35,000$1.8MEXIT
Joel Greenblatt0.00%16,497$869.7KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q2 2026004$0—
Q1 2026421$67.9M$52.72
Q4 2025300$60.7M$40.40